Globus Medical, Inc. logo GMED - Globus Medical, Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 27
HOLD 8
SELL 1
STRONG
SELL
0
| PRICE TARGET: $110.29 DETAILS
HIGH: $117.00
LOW: $100.00
MEDIAN: $112.00
CONSENSUS: $110.29
UPSIDE: 30.04%
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009
Revenue
Revenue 2,938.9 2,519.4 1,568.5 1,022.8 958.1 789.0 785.4 713.0 636.0 564.0 544.8 474.4 434.5 386.0 331.5 288.2 254.3
Cost of Revenue 957.8 1,035.5 548.2 263.7 239.2 217.5 180.0 159.4 150.5 134.7 132.3 110.8 100.3 75.2 68.8 53.8 41.6
Gross Profit 1,981.1 1,483.9 1,020.3 759.1 718.9 571.6 605.4 553.6 485.5 429.3 412.4 363.6 334.1 310.8 262.7 234.4 212.7
Operating Expenses
R&D Expenses 185 163.8 124.0 73.0 97.3 84.5 60.1 55.5 43.7 44.5 36.3 31.2 26.9 27.9 23.5 21.3 20.5
SG&A Expenses 1,316.3 981.0 643.4 432.1 408.1 354.8 354.8 311.6 267.8 222.2 214.0 187.8 182.5 168.9 140.4 122.6 108.4
Other Expenses 0 173.1 119.7 26.0 41.4 20.9 18.6 17.1 12.2 8.5 (6.4) 5.4 23.1 (0.8) 1.5 2.8 1.9
Operating Expenses 1,501.3 1,317.9 887.2 531.2 546.9 460.1 433.4 384.2 323.7 275.1 240.2 225.2 232.4 196.0 165.3 146.7 130.8
Operating Income
Operating Income 479.8 166.0 133.1 228.0 172.0 111.4 172.0 169.3 161.8 154.1 172.2 138.4 101.7 114.8 97.4 87.7 81.9
Interest Expense 0 4.2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Interest Income 7.1 0 20.1 14.2 9.3 14.0 17.4 13.3 6.6 3.1 1.3 0.8 0.5 0.1 0 0 0
Profitability
EBITDA 729.9 473.7 346.6 304.5 264.7 178.3 229.5 218.5 205.4 193.0 195.6 159.6 120.9 132.7 115.8 105.7 97.3
EBIT 609.9 219.7 201.8 236.3 194.9 115.5 176.8 176.9 163.3 154.2 171.5 137.8 101.5 114.6 98.8 90.5 83.8
Income Before Tax 609.9 120.7 165.4 243.0 180.4 125.9 189.9 188.6 169.9 157.3 172.8 138.6 102.0 114.7 96.9 87.7 81.8
Income Tax Expense 72 17.7 42.5 52.9 31.2 23.6 34.7 32.1 62.6 52.9 60.0 46.2 33.4 40.8 36.2 33.3 29.7
Net Income 537.9 103.0 122.9 190.2 149.2 102.3 155.2 156.5 107.3 104.3 112.8 92.5 68.6 73.8 60.8 54.5 48.7
Per Share Data
EPS (Basic) 3.98 0.76 1.09 1.89 1.48 1.04 1.57 1.60 1.12 1.09 1.19 0.98 0.74 0.82 0.84 0.75 0.55
EPS (Diluted) 3.92 0.75 1.07 1.85 1.44 1.01 1.52 1.54 1.10 1.08 1.17 0.97 0.73 0.80 0.81 0.72 0.54
Shares Outstanding 135.2 135.7 113.1 100.5 100.7 98.6 99.2 97.9 96.2 95.6 95.0 94.2 92.6 89.6 72.7 72.7 88.1
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016
Current Assets
Cash & Cash Equivalents 526.2 784.4 467.3 150.5 193.1 239.4 195.7 139.7 118.8 67.0
Short-Term Investments 31.1 105.6 50.5 295.6 250.4 187.3 115.8 199.9 254.9 223.4
Net Receivables 678.9 578.3 504.9 217.3 165.7 148.1 162.4 144.4 127.1 95.8
Inventory 759.3 659.2 848.1 299.0 237.0 229.2 196.3 131.3 108.4 112.7
Other Current Assets 130.2 49.6 44.6 21.0 0 0 0 0.1 0 0.5
Total Current Assets 2,125.6 2,177.3 1,915.4 983.3 864.5 821.8 687.5 630.7 620.3 513.8
Non-Current Assets
Property, Plant & Equipment 628.2 611.6 646.9 243.7 221.1 216.9 199.8 171.9 143.2 124.2
Goodwill 1,435.0 1,432.4 1,434.5 197.5 179.7 156.7 128.8 123.7 123.9 105.9
Intangible Assets 745.1 795.1 924.6 63.6 68.7 86.9 78.8 87.3 78.7 61.7
Long-Term Investments 0 66.1 75.4 495.9 562.5 358.5 409.5 263.1 56.1 60.4
Other Non-Current Assets 150.6 75.1 78.6 43.3 36.3 32.0 21.7 10.4 36.3 30.9
Total Non-Current Assets 3,177.2 3,074.5 3,170.7 1,092.8 1,092.7 857.7 844.6 670.0 458.2 413.9
Total Assets 5,302.8 5,251.8 5,086.1 2,076.1 1,957.3 1,679.5 1,532.1 1,300.7 1,078.5 927.6
Current Liabilities
Account Payables 98.9 75.1 56.7 36.1 22.0 18.2 24.6 25.9 25.0 17.5
Short-Term Debt 14.7 443.4 0 0 0 0 0 0 0 0
Deferred Revenue 27.7 22.1 18.4 14.1 12.0 8.1 5.4 2.6 0.8 0
Other Current Liabilities 357.3 185.6 201.9 66.7 64.2 50.7 43.9 39.3 40.4 37.3
Total Current Liabilities 498.5 855.9 392.3 159.2 140.2 120.8 111.4 96.1 93.1 79.9
Non-Current Liabilities
Long-Term Debt 103.9 0 417.4 0 0 0 0 0 0 0
Deferred Tax Liabilities 23.8 23.9 84.4 1.8 4.3 6.2 6.0 8.1 10.7 7.9
Other Non-Current Liabilities 103.3 111.0 102.9 65.3 71.4 46.2 12.2 10.9 7.0 7.8
Total Non-Current Liabilities 231.0 218.5 695.8 70.5 75.7 52.4 18.2 19.0 17.7 15.7
Total Liabilities 729.5 1,074.4 1,088.1 229.8 215.9 173.2 129.6 115.2 110.7 95.6
Stockholders' Equity
Common Stock 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1
Retained Earnings 1,388.0 1,152.8 1,137.3 1,240.0 1,194.3 1,045.1 1,047.9 892.7 736.2 628.9
Accumulated Other Comprehensive Income 15.3 (6.9) (10.2) (24.6) (6.8) 4.0 (2.9) (7.2) (6.9) (8.6)
Total Stockholders' Equity 4,573.2 4,177.3 3,998.0 1,846.4 1,741.4 1,506.3 1,402.5 1,185.5 967.8 832.1
Total Liabilities & Equity 5,302.8 5,251.8 5,086.1 2,076.1 1,957.3 1,679.5 1,532.1 1,300.7 1,078.5 927.6
Debt Metrics
Total Debt 118.7 537.2 520.4 6.0 0 0 0 0 0 0
Net Debt (407.5) (247.2) 53.1 (144.5) (193.1) (239.4) (195.7) (139.6) (118.8) (67.0)
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016
Operating Activities
Net Income 537.9 103.0 122.9 190.2 149.2 102.3 155.2 156.5 107.3 104.3
Depreciation & Amortization 276.8 254.0 144.7 68.3 69.9 62.9 52.7 41.6 42.1 38.8
Stock-Based Compensation 49.8 54.2 52.7 32.8 30.6 27.1 26.1 21.9 14.7 11.4
Change in Working Capital (82.7) (97.6) (116.6) (105.3) (17.3) (37.6) (73.4) (49.9) (30.5) 3.5
Other Non-Cash Items (47.0) 332.9 97.5 14.7 61.5 48.5 7.1 10.5 17.7 17.7
Operating Cash Flow 753.4 520.6 243.5 178.5 276.3 198.8 172.0 181.6 159.5 171.9
Investing Activities
Capital Expenditure (164.7) (115.4) (78.3) (74.0) (56.9) (63.7) (70.8) (59.7) (51.3) (40.9)
Acquisitions 13.5 (17.6) (296.0) (31.4) (34.5) (33.5) (23.8) (14.8) (29.9) (76.1)
Purchases of Investments (107.5) (113.5) (100.6) (419.5) (622.4) (223.5) (346.5) (537.9) (392.9) (287.3)
Sales/Maturities of Investments 179.5 70.5 777.9 414.7 337.8 203.4 300.8 384.4 362.9 334.7
Other Investing Activities (275.8) 0 0 0 0 0 0 35 0 (30)
Investing Cash Flow (355.0) (176.1) 303.0 (110.4) (375.9) (117.3) (140.3) (193.0) (111.3) (99.6)
Financing Activities
Net Debt Issuance 0 0 0 0 0 0 0 0 0 0
Stock Repurchased (300.5) (85.8) (225.6) (144.5) 0 (104.7) 0 0 0 0
Dividends Paid 0 0 0 0 0 0 0 0 0 0
Other Financing Activities (378.7) 58.1 (6.3) 34.5 54.1 66.0 (6.6) (6.7) (10.1) (5.4)
Financing Cash Flow (679.2) (27.7) (231.8) (110.0) 54.1 (38.7) 24.4 32.6 1.6 2.0
Cash Position
Net Change in Cash (258.3) 317.1 316.8 (42.6) (46.3) 43.7 56.0 20.9 51.9 72.5
Cash at Beginning 784.4 467.3 150.5 193.1 239.4 195.7 139.7 118.8 67.0 60.2
Cash at End 526.2 784.4 467.3 150.5 193.1 239.4 195.7 139.7 118.8 132.6
Free Cash Flow 588.8 405.2 165.2 104.4 219.4 135.1 101.2 121.9 108.2 131.0
Key Metrics 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009
Income Statement
Revenue 2,938.9 2,519.4 1,568.5 1,022.8 958.1 789.0 785.4 713.0 636.0 564.0 544.8 474.4 434.5 386.0 331.5 288.2 254.3
Gross Profit 1,981.1 1,483.9 1,020.3 759.1 718.9 571.6 605.4 553.6 485.5 429.3 412.4 363.6 334.1 310.8 262.7 234.4 212.7
Operating Income 479.8 166.0 133.1 228.0 172.0 111.4 172.0 169.3 161.8 154.1 172.2 138.4 101.7 114.8 97.4 87.7 81.9
Net Income 537.9 103.0 122.9 190.2 149.2 102.3 155.2 156.5 107.3 104.3 112.8 92.5 68.6 73.8 60.8 54.5 48.7
EPS (Diluted) 3.92 0.75 1.07 1.85 1.44 1.01 1.52 1.54 1.10 1.08 1.17 0.97 0.73 0.80 0.81 0.72 0.54
Balance Sheet
Cash & Equivalents 526.2 784.4 467.3 150.5 193.1 239.4 195.7 139.7 118.8 67.0
Total Assets 5,302.8 5,251.8 5,086.1 2,076.1 1,957.3 1,679.5 1,532.1 1,300.7 1,078.5 927.6
Total Debt 118.7 537.2 520.4 6.0 0 0 0 0 0 0
Stockholders' Equity 4,573.2 4,177.3 3,998.0 1,846.4 1,741.4 1,506.3 1,402.5 1,185.5 967.8 832.1
Cash Flow
Operating Cash Flow 753.4 520.6 243.5 178.5 276.3 198.8 172.0 181.6 159.5 171.9
Capital Expenditure (164.7) (115.4) (78.3) (74.0) (56.9) (63.7) (70.8) (59.7) (51.3) (40.9)
Free Cash Flow 588.8 405.2 165.2 104.4 219.4 135.1 101.2 121.9 108.2 131.0